USNA

Usana Health Sciences
$14.83
−$0.29 (−1.92%)Sep 10, 2026
3.9FairMoatMint rating

MoatMint rates Usana Health Sciences (USNA) 3.9 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 6.1 out of 10.

Key metrics

The numbers that frame USNA today
Market cap
$274.01M
P/E (TTM)
-12.4
EV / FCF
5.3
Gross margin
77.4%
EV / Sales
0.1
ROIC
5.1%
Div yield
0%
Debt / equity
0.0
52wk Low
$12.57
52wk High
$31.11

USNA stock rating

How USNA scores on quality, value, growth, momentum and financial health
3.9out of 10
Fair overallNeutral business, attractive price
Quality6.1
Growth0.7
Momentum1.4
Value9.7
Financial Health4.8

Growth

Revenue and earnings trend for USNA
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about USNA
Is Usana Health Sciences a good buy?
No. Usana Health Sciences has strong quality, but poor momentum undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Usana Health Sciences is selling at a low price, but price alone does not change the weak overall picture.
What is the market capitalization of USNA?
Usana Health Sciences's market capitalization is $274.01M.
What is the P/E ratio for USNA stock?
Usana Health Sciences's current P/E ratio is -12.4.
What is the 52-week high for USNA stock?
The 52-week high for Usana Health Sciences is $31.11. The current close of $14.83 is 52.3% below that high.
What is the 52-week low for USNA stock?
The 52-week low for Usana Health Sciences is $12.57. The current close of $14.83 is 18% above that low.
Does USNA stock pay dividends?
Usana Health Sciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for USNA?
Usana Health Sciences's Debt / Equity ratio is 0.